Peter Carroll MD, MPH
Professor and Chair, Department of Urology, University of California, San Francisco, School of Medicine; Associate Dean, UCSF School of Medicine; Director, Strategic Planning and Clinical Services, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CaliforniaDr. Peter Carroll holds the Ken and Donna Derr—Chevron Texaco Distinguished Professorship in Prostate Cancer at the University of California, San Francisco, School of Medicine, where he is also the chair of the Department of Urology. He is the Director of Strategic Planning and Clinical Services of the UCSF Helen Diller Family Comprehensive Cancer Center and Associate Dean of the UCSF School of Medicine. Dr. Carroll received his medical degree from Georgetown University School of Medicine in Washington, DC, completed general surgery training and urology residency at UCSF, and completed a fellowship in urologic oncology at Memorial-Sloan Kettering Cancer Center in New York. In 2008, Dr. Carroll received an MPH from the University of California, Berkeley.
Recent Contributions to PracticeUpdate:
- Personalised Biopsy Schedules for Patients With Low-Risk Prostate Cancer on Active Surveillance
- Outcome Equivalency Between Radical Prostatectomy and Prostate Radiotherapy
- Biochemical Recurrence Outcomes After Radical Prostatectomy and Radiation Therapy
- On the Look Out for High Specificity: Identifying Significant Disease in Active Surveillance
- ERG Expression Associated With Increased Risk for Progression During Active Surveillance for Prostate Cancer
- Histologic Grade Progression of PCa Common Even With Negative Confirmatory Biopsy
- Radical Prostatectomy vs Watchful Waiting in Early Prostate Cancer
- Long-Term Results Are In: Radical Prostatectomy Wins Over Watchful Waiting
- Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
- Prostatectomy Still Superior to Watchful Waiting Over Long Term